CAT1, FTF2B, etc.
Inhibit growth and proliferation and increase senescence of HepG2 cells
ADAM10, IGF1R, CCNG1
Render HepG2 cells more sensitive to chemotherapeutic agents and inhibit HCC cells proliferation
Reduce HCC cell viability and proliferation and reduce expression of ERK1/2
MHCC97L, MHCC97H, Huh7, and HepG2 cells
CDC42, TCF3, CDK2, etc.
Inhibit recipient cell proliferation and invasion and reduce HCC tumor in size
Normal fibroblasts in lung tissues
Promote the conversion of normal fibroblasts to CAFs and accelerate lung metastasis of HCC
MHCC97-H cells and SMMC-7721 cells
Inhibit tumor progression by suppressing MAPK pathway
Inhibit HCC cell proliferation
HepG2 and Hep3B cells
Suppress EGFR/AKT/ERK1/2 pathway and inhibit migration of HCC cells
miR-584, miR-517c, miR-378, etc.
TAK1, TAB2, etc.
Associate with hepatocarcinogenesis and enhance transformed cell growth in recipient cells
Arsenite-transformed L-02 cells
Native L-02 and THLE-3 cells
Promote inflammatory infiltration and HCC